Investment Guru Paul Mampilly Exposes Readers to Major Medical Investment Opportunity

Profits Unlimited is a newsletter run by Paul Mampilly. He uses the newsletter as a way to inform his readers of stocks that will provide the highest rate of return. Profits Unlimited has established an engaged community of considerable size. Upwards of 90,000 readers are subscribed to the newsletter. Mampilly also authors another newsletter titled, Extreme Fortunes and operates a research service by the name of True Momentum.

He recommended precision medicine as an investment in the Profits Unlimited newsletter. Mampilly expressed that there is a revolution going on in precision medicine and it will lead to taking up a significant portion of the market share in the healthcare industry. According to Paul Mampilly, precision medicine is the “greatest medical breakthrough” of all time. He went on to advocate further, saying that it is more crucial and useful than every medical device, vaccination, and drug the modern world currently has available. He feels that Precision medicine will spur a health Revolution that will provide disease solutions. Follow Paul Mampilly on Facebook.

So what is precision medicine exactly? This type of medication works by being customized for the genetic makeup of a particular individual. The concept behind it is that your treatment involves medicine that prevents your body from developing a specific disease.


Compare this to a tailored outfit that is made bespoke, just for you and can prevent the development of specific conditions. For example conditions such as Parkinson’s, Alzheimer’s, and heart disease are treated according to the person’s DNA. If a person has already developed a condition, precision medicine helps medical professionals select the most beneficial treatment. The primary focus of precision medicine treatment is the examination of a person’s genes.

As a part of his experience, Mampilly managed accounts valued in the millions of dollars in 1991. Subsequently, he operated Kinetics Asset Management’s hedge fund. He successfully increased the assets of the firm to $25 billion. The fund that he managed received the honor of Barron’s title of “World’s Best” due to the astounding 26% annual returns delivered by the fund.

Mampilly also was invited to join an investment competition by the Templeton Foundation. He entered the contest with $50 million and exited at $88 million. Mampilly managed to achieve this feat during America’s financial crisis during 2008 and 2009. His expertise has earned him features on Fox Business News, CNBC, and Bloomberg to name a few. More information can be found by visiting: https://paulmampillyguru.com/